发明名称 COMBINATIONS OF TETRACYCLIC CYCLIC GMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS WITH FURTHER THERAPEUTIC AGENTS
摘要 A compound of formula (I) and salts and solvates thereof, in which: R0 represents hydrogen, halogen, or C1-6alkyl; R1 represents hydrogen, C1-6-alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl, C3 - 8cycloalkyl, C3-8cyloalkylC1-3alkyl, arylC1-3alkyl, or heteroarylC1-3alkyl; R2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan, and pyridine, or an optionally substituted bicyclic ring (a) attached to the rest of the molecule via one of the benzene ring carbon atoms, and wherein the fused ring (A) is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated, and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur, and nitroge n; and R3 represents hydrogen or C1-3alkyl, or R1 and R3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and selective inhibitor of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase (cGMP specific PDE ) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders and erectile dysfunction.
申请公布号 CA2340636(C) 申请公布日期 2007.08.07
申请号 CA19992340636 申请日期 1999.08.26
申请人 ICOS CORPORATION 发明人 GELLIBERT, FRANCOISE;DAUGAN, ALAIN CLAUDE-MARIE
分类号 A61K31/4985;A61K45/00;A61K31/198;A61K31/21;A61K31/403;A61K31/417;A61K31/4245;A61K31/455;A61K31/475;A61K31/495;A61K31/5377;A61K31/5575;A61K31/5585;A61K33/26;A61K38/00;A61K45/06;A61P1/00;A61P1/04;A61P9/00;A61P9/02;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P13/08;A61P13/12;A61P15/04;A61P15/10;A61P19/10;A61P27/06;A61P29/00;A61P35/00;A61P37/08;A61P43/00;C07D471/14 主分类号 A61K31/4985
代理机构 代理人
主权项
地址